Photo via Times of India

Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain

Read the original at Times of India ↗
Cite

Sharma, M. (2026, October 24). Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain. Times of India. https://timesofindia.indiatimes.com/world/rest-of-world/with-no-approved-vaccine-for-ebola-strain-who-begins-first-clinical-trial-in-dr-congo/articleshow/135160610.cms

Dated from the outlet's own feed. Check the original for its byline.

Times of India · collected 2026-10-24 · by Mahima Sharma analysis

Quick Summary

The World Health Organization (WHO) has initiated a clinical trial called Tumaini in Bunia, DRC, to test whether the Ervebo Ebola vaccine can provide protection against the Bundibugyo strain of the virus. This follows the DRC's 17th and most severe Ebola outbreak, which has resulted in over 9,700 cases and more than 4,600 deaths since May. The trial will assess two additional experimental vaccines, one from Oxford University and another from Moderna, to determine their effectiveness against the Bundibugyo strain.
Written by AI on 2026-10-24, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

As of October 24, 2026, the World Health Organization (WHO) began a clinical trial for an Ebola vaccine called Ervebo in Bunia, Democratic Republic of Congo (DRC), at the epicenter of the ongoing outbreak. The trial aims to determine if Ervebo offers any protection against the Bundibugyo strain of the virus, which is causing the current epidemic. Dr. Tedros Adhanom Ghebreyesus, WHO's director-general, announced this development on X (formerly Twitter), stating it would help assess vaccine candidates for the Bundibugyo virus.

The DRC declared its 17th Ebola outbreak in May 2026, which has since become the country’s worst on record with over 9,700 cases and more than 4,600 deaths. The WHO declared a public health emergency of international concern due to this outbreak spreading across four African countries, marking its widest geographical spread ever in Africa.

This trial is crucial as it could provide insights into whether existing vaccines can offer cross-protection against different Ebola strains, potentially aiding control measures and saving lives during the ongoing crisis.

Written for “Ebola Vaccine Clinical Trial In DRC” on 2026-11-21, grounded in this article and the 1 other(s) covering the same event.

How they differ

2 outlets covered “Ebola Vaccine Clinical Trial In DRC”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

Times of IndiaThis outlet24 Oct

The World Health Organization (WHO) has initiated a clinical trial called Tumaini in Bunia, DRC, to test whether the Ervebo Ebola vaccine can provide protection against the Bundibugyo strain of the virus. This follows the DRC's 17th and most severe Ebola outbreak, which has resulted in over 9,700 cases and more than 4,600 deaths since May. The trial will assess two additional experimental vaccines, one from Oxford…

Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain (this article)
Al Jazeera24 Oct

The World Health Organization announced the start of a clinical trial in Bunia, DRC, for an Ebola vaccine called Ervebo, which will test its effectiveness against the Bundibugyo strain of the virus. The trial involves a ring vaccination approach and includes two additional candidate vaccines: one from the University of Oxford and another from Moderna. Both vaccines are expected to enter the trial soon. This…

WHO announces start of Ebola vaccine clinical trial in DR Congo →

Compared with similar articles

This article reads unscored and hedges 17% of its claims. Each row says how that neighbour differs.
Al Jazeera
Hedges 2 of 15 claims Outlet record 60/100
Toronto Star
Hedges 3 of 37 claims Outlet record 64/100
“Article A describes the spread of the Ebola outbreak across multiple African countries, while Article B reports on a WHO trial launching an Ebola vaccine study in DRC specifically for the Bundibugyo strain. These are different events.”
CBC News
Hedges 3 of 26 claims Outlet record 60/100
“Article A reports on the launch of a clinical trial for an Ebola vaccine in response to the outbreak, while Article B discusses the overall spread and statistics of the ongoing Ebola cases in DRC.”

Story

Ebola Vaccine Clinical Trial In DRC
Health · 2 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
18
sentences that state something as happening or true
Uncertain
17%
3 of 18 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
59/100
Times of India's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-24 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Times of India · 5474 article(s) · 6 correction(s) detected
Running correction rate · 6 correction(s)

Who wrote this

Mahima Sharma
66 article(s) here · 1 carrying a prediction
Kobir warned that the government would respond strongly to such attacks.
Thousands of residents could be affected as days of heavy rainfall flow into the St. Johns River and its surrounding lakes, according to meteorologists from the National Weather Service in Melbourne.
Small island nations are urging governments to preserve this target, arguing that exceeding it could have devastating consequences for their populations. “For us, it's really not a temperature threshold, it's a survival threshold,” said Adelle Thomas, senior director at the Natural Resources Defense Council and a native of the Bahamas.
House democrats will hold a private meeting to elect their leadership for the upcoming Congress and nominate Jeffries for the top position.
Even without the Alaska result, democrats would have achieved their largest senate majority since January 2015.
Ozgur Ozel, leader of the main opposition new party, condemned the raid and accused Erdogan's government of being unwilling to tolerate criticism or uncomfortable truths.
Robin Li, chairman and chief executive of Chinese technology company Baidu, warned on Tuesday that fears of an artificial intelligence (AI) bubble could turn into reality if massive investments in the technology fail to deliver higher revenues and profits for businesses, according to news agency Reuters.
PAHO is expected to formally announce the decision on Tuesday.
A powerful El Niño weather pattern could persist until early 2027, with forecasters warning that its effects may vary significantly across the United States, bringing warmer temperatures to some regions and heavy rainfall to others.
Confused passengers repeatedly checked departure updates, hoping their flights would eventually receive clearance to take off.
Also by Mahima Sharma
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 66 articles by Mahima Sharma →

Topics

DRC Ervebo The World Health Organization WHO the Democratic Republic of Congo

Subjects

WHO ORG · 5× DRC GPE · 4× Bunia GPE · 1× Congo GPE · 1× Ituri GPE · 1× Tedros PERSON · 1× Tedros Adhanom Ghebreyesus PERSON · 1× The World Health Organization ORG · 1× Zaire GPE · 1× the Democratic Republic of Congo GPE · 1×

Narrative

The outbreak has also been reported in four countries across eastern, central and western Africa, marking the widest geographical spread of an Ebola outbreak on the continent so far. Multiple vaccine candidates to be assessed Known as the Tumaini trial, the initiative follows a single clinical trial framework designed to evaluate the safety, effectiveness and immunogenicity of multiple vaccine candidates.
framing: assertive · carried by 1 article(s) · first seen 2026-10-24
The trial will assess whether Ervebo, which is approved for protection against the Zaire strain of Ebola, can provide any cross-protection against the Bundibugyo virus responsible for the current epidemic, according to news agency AP.

Claims (18 extracted, 3 hedged)

The World Health Organization (WHO) has announced the launch of the first clinical trial of an Ebola vaccine during the ongoing outbreak in the Democratic Republic of Congo (DRC). asserted
Organization → announce → Congo
WHO director-general Tedros Adhanom Ghebreyesus said on Friday that the first participants had received the Ervebo vaccine in Bunia, the capital of Ituri province in northeastern DRC, which is at the centre of the outbreak. asserted
which → say → outbreak
The trial will assess whether Ervebo, which is approved for protection against the Zaire strain of Ebola, can provide any cross-protection against the Bundibugyo virus responsible for the current epidemic, according to news agency AP. uncertain
which → assess → AP
“This trial will help us understand whether any of the vaccine candidates designed for Bundibugyo virus work,” Tedros said in a post on X. DR Congo reports thousands of Ebola cases asserted
Congo → help → cases
The DRC declared its 17th Ebola outbreak in May, which has become the country's worst on record. uncertain
which → declare → record
Since then, the outbreak has resulted in more than 9,700 reported cases and over 4,600 deaths. asserted
outbreak → result → cases
In response to the crisis, the WHO declared a public health emergency of international concern, its second-highest level of alert. asserted
WHO → declare → alert
The outbreak has also been reported in four countries across eastern, central and western Africa, marking the widest geographical spread of an Ebola outbreak on the continent so far. Multiple vaccine candidates to be assessed Known as the Tumaini trial, the initiative follows a single clinical trial framework designed to evaluate the safety, effectiveness and immunogenicity of multiple vaccine candidates. asserted
initiative → report → candidates
The study will adopt a ring vaccination strategy, under which people identified as close contacts of infected individuals and considered at high risk of contracting the virus will be vaccinated. asserted
people → adopt → virus
In addition to Ervebo, the trial is expected to include two experimental vaccines specifically developed against the Bundibugyo virus. asserted
trial → expect → virus
Both candidates are currently progressing through smaller, early-stage clinical studies. asserted
candidates → progress → studies
One candidate is an adenoviral vector vaccine, ChAdOx1, being developed by the University of Oxford. asserted
candidate → develop → Oxford
The other is an mRNA-based vaccine developed by US biotechnology company Moderna. asserted
other → base → Moderna
The coalition for epidemic preparedness innovations (CEPI) has funded both candidates and said they are expected to enter the trial shortly. asserted
they → fund → trial
The study will also include pregnant women and children aged 12 years and above, helping generate evidence for groups that are frequently excluded from clinical research. asserted
that → include → research
WHO stresses need for evidence on vaccine protection WHO emergencies director Chikwe Ihekweazu said the trial had been designed to produce robust scientific evidence on whether the participating vaccines could protect people at risk of infection. uncertain
vaccines → stress → infection
The findings are expected to help researchers determine whether the existing vaccine and the experimental candidates can offer protection against the Bundibugyo strain, for which vaccine options remain limited. asserted
options → expect → which
The trial represents an important step in efforts to evaluate potential vaccines amid the ongoing Ebola emergency in the DRC and other affected parts of Africa. asserted
trial → represent → Africa
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support